Results

Total Results: 406 records

Showing results for "company".

141. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - telaprevir treatment is about four times higher than boceprevir ($117.14 per 375 mg capsule); the company … The current average wholesale price is about $117 per 375 mg capsule; the company set the price at … $49,200 for a 12-week regimen. 12 The company introduced a copay assistance program for patients

142. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
     September 13, 2006 - Slide 1 Marketing “evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals Presented by W. Douglas Evans, Ph.D. Lauren McCormack, Ph.D., M.S.P.H Presented at Agency for Healthcare Research and Quality Conference: Communicating Harms and Benefits of …

143. Arthritis-Knee-Physical-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-knee-physical-therapy_research-protocol.pdf
     April 01, 2010 - Source: www.effectivehealthcare.ahrq.gov Published Online: March 02, 2011 1 Evidence-based Practice Center Systematic Review Protocol Comparative Effectiveness of Physical Therapy for Knee Pain Secondary to Osteoarthritis I. Background and Objectives for the Systematic Review Osteoarthritis (OA) is a…

144. DARTNet Summary Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
     July 01, 2009 - In addition, small practices often used a local cable or phone company that served as the Internet … This hardware often had poor or no documentation and nobody at the phone or cable company could assist … Likewise, data from a payer or pharmacy benefits management company reflects prescriptions actually

145. AHRQ Slide Template 2019-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
     January 01, 2023 - Interventions or policies established by entities other than healthcare providers, such as: Insurance company

146. Clinical-Care-Rapid-Review-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
     January 01, 2018 - Committee CEO Chief Executive Officer CI confidence interval CRICO RMF Controlled Risk Insurance Company … applied: NR Multiple events per patient: Unclear Not specified NR NR NR Baystate Health Insurance Company … Baystate Health Insurance Company, Blue Cross Blue Shield of Massachusetts, CRICO RMF, Coverys, Harvard

147. Methods Research Report Improving Access To And Usability of Systematic Review Data for Health Systems Guideline Development (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-health-systems-guidelines-development.pdf
     February 01, 2019 - However, we were unable to reach the development team or parent company for VizSweet after repeated … and dice • Currently not available for commercial use • No response from development team or company

148. 15 Crosscutting Potential High Impact June 2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
     January 01, 2012 - The company received marketing clearance from the U.S. … The 6 company received Conformité Européene (CE) mark approval to market the complete Raisin

149. Disclosure Policy and Form (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
     March 01, 2023 - Disclosure Policy and Form AHRQ Evidence-based Practice Center Policy on Financial and Nonfinancial Interests Background and Purpose of Policy To maintain public confidence in the scientific integrity and credibility of work produced by the EPC Program, it is essential that all aspects of the process and metho…

150. Newly Medicare-Eligible Elders: Data Points #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
     June 01, 2012 - Public Health, Division of Health Policy and Management, Min- neapolis, MN. 2 Buccaneer, A Vangent Company

151. DEcIDE DRN Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-proof_research.pdf
     June 01, 2010 - developed in collaboration with Lincoln Peak Partners, a privately-held information technology services company

152. Carbohydrate-Intake-Prepub-Final-Research-Table-Da (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-prepub-final-research-table-da.xlsx
     January 01, 2019 - outcomes (related to KQ) Databases from the Campbell Institute of Research and Technology (Campbell Soup Company

153. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - machine dispenses the EC pills at $25 per dose and charges students only what the pharmaceutical company

154. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1306.pdf
     June 11, 2013 - machine dispenses the EC pills at $25 per dose and charges students only what the pharmaceutical company

155. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_ii1.ppt
     June 01, 2011 - Slide 1 Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators Numeric

156. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - 1 Comparative Effectiveness Review Number 54 Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report Executive Summary Background Psoriatic arthritis (PsA) is among the most disabling forms of arthritis, even though it affects fewer people than other types of arthritis. PsA has a highly variabl…

157. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - 1 Comparative Effectiveness Review Number 55 Drug Therapy for Rheumatoid Arthritis in Adults: An Update Executive Summary Background Rheumatoid arthritis (RA), which affects 1.3 million adult Americans, is an autoimmune disease that involves inflammation of the synovium (a thin layer of tissue lining a joint …

158. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - 1 Source: www.effectivehealthcare.ahrq.gov Published online: July 24, 2013 Evidence-based Practice Center Systematic Review Protocol Project Title: Medication Therapy Management I. Background and Objectives for the Systematic Review The Medicare Prescription Drug, Improvement, and Modernization Act of …

159. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - In November 2014, the company submitted a new drug application to FDA for a fixed- dose combination … However, one pharmacy benefit management company estimated that fixed-dose combination lumacaftor/ivacaftor … In November 2014, the company submitted a new 3 drug application to the U.S.

160. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
     December 06, 2016 - patient who is motivated and entering treatment must be told to wait a few days for his insurance company … It seems ridiculous for a health- care provider to have to tell an insurance company (Medicaid included … for imminent death due to overdose; it seems unconscionable to permit non- evidence-based insurance company